Publisher
Springer International Publishing
Reference44 articles.
1. Arnold JJ, Campain A, Barthelmes D, et al. Two-year outcomes of “treat and extend” intravitreal therapy for neovascular age-related macular degeneration. Ophthalmology. 2015;122(6):1212–9.
2. Freund KB, Zweifel SA, Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina. 2010;30(9):1333–49.
3. Wu K, Zhang X, Su Y, et al. Clinical characteristics of inflammatory choroidal neovascularization in a Chinese population. Ocul Immunol Inflamm. 2016;24(3):261–7.
4. Shoughy SS, Jaroudi MO, Tabbara KF. Regression of peripapillary choroidal neovascular membrane in a patient with sarcoidosis after oral steroid therapy. Saudi J Ophthalmol. 2014;28(2):160–2.
5. Nobrega MJ, et al. Anecortave may help choroidal neovascularization regression in serpiginous choroiditis. Can J Ophthalmol. 2007;42(1):151–2.